Renaissance Technologies - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 23 filers reported holding ATYR PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q3 2023$799
-29.7%
505,993
-3.9%
0.00%
-50.0%
Q2 2023$1,137
+243.5%
526,355
+233.9%
0.00%
Q1 2023$331
-9.1%
157,655
-5.1%
0.00%
Q4 2022$364
-99.9%
166,076
-11.4%
0.00%
-100.0%
Q3 2022$563,000
+31.9%
187,525
+24.3%
0.00%0.0%
Q2 2022$427,000
-28.0%
150,825
+36.1%
0.00%0.0%
Q1 2022$593,000
-37.6%
110,855
-12.8%
0.00%0.0%
Q4 2021$950,000
-41.8%
127,155
-29.2%
0.00%
-50.0%
Q3 2021$1,631,000
+89.7%
179,655
+1.9%
0.00%
+100.0%
Q2 2021$860,000
-20.1%
176,255
-27.2%
0.00%0.0%
Q1 2021$1,077,000
-13.0%
241,960
-24.2%
0.00%0.0%
Q4 2020$1,238,000
-6.1%
319,130
-21.9%
0.00%0.0%
Q3 2020$1,319,000
-18.8%
408,430
+11.6%
0.00%0.0%
Q2 2020$1,624,000
+177.6%
365,830
+75.0%
0.00%0.0%
Q1 2020$585,000
-29.9%
209,000
+4.5%
0.00%0.0%
Q4 2019$834,000
+23.0%
199,920
+3.3%
0.00%0.0%
Q3 2019$678,000193,6200.00%
Other shareholders
ATYR PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Tikvah Management LLC 1,225,833$9,157,0002.55%
Stonepine Capital Management, LLC 525,531$3,926,0001.80%
Telemetry Investments, L.L.C. 176,782$1,321,0001.70%
TANG CAPITAL MANAGEMENT LLC 1,113,453$8,317,0001.67%
VR Adviser, LLC 1,565,000$11,691,0001.60%
Deep Track Capital, LP 1,100,000$8,217,0000.58%
EAM Investors, LLC 252,280$1,885,0000.31%
EAM Global Investors LLC 152,792$1,141,0000.20%
FEDERATED HERMES, INC. 5,222,250$39,010,0000.07%
Alyeska Investment Group, L.P. 674,975$5,042,0000.06%
View complete list of ATYR PHARMA INC shareholders